LATS1 and soft tissue sarcoma: Loss of function of either LATS1 or LATS2 leads to a variety of tumor types including soft tissue sarcomas, leukemia, as well as breast, prostate, lung and esophageal cancers [18], which suggests they function as tumor suppressors in tumor pathogenesis.